Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence
Ciro Celsa; Caterina Stornello; Paolo Giuffrida; Carmelo Marco Giacchetto; Mauro Grova; Gabriele Rancatore; Concetta Pitrone; Vito Di Marco; Calogero Cammà; Giuseppe Cabibbo;
Ann Hepatol. 2022;27 Supl 1:
Trends and health inequalities of hepatitis virus-associated liver cancer mortality during 1990¿2050
Yujiao Deng; Jingyue Tan; Jian Zu; Zixuan Xing; Zhanpeng Yang; Yue Zhang; Yajing Bo; Xu Gao; Enrui Xie; Yuan Wang; Meijuan Han; Fanpu Ji; Yang Yang;
Ann Hepatol. 2026;31:
Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma
Stephen Lam Chan; Richard S. Finn; Julien Edeline; Sadahisa Ogasawara; Jennifer J. Knox; Bruno Daniele; Baek-Yeol Ryoo; Philippe Merle; Mohamed Bouattour; Ho-Yeong Lim; Yee Chao; Thomas Yau; Barbara Anne Haber; Usha Malhotra; Abby B. Siegel; Chih-Chin Liu; Masatoshi Kudo; Ann-Lii Cheng;
10.1016/j.aohep.2025.102169